Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
Sakarya, Turkey
Hospital in Sakarya
Şirinevler, Adnan Menderes Cad.Sağlık Sok No - 195, 54100 Adapazarı/Sakarya
About Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Merck Sharp & Dohme LLC
2
Amgen
1
BioNTech SE
1
Clinical Trials at Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
During the past decade, Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
2018-10-05
2024-12-30
Active, not recruiting
732
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
2018-11-08
2024-09-28
Active, not recruiting
1,579
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2020-02-07
2025-12-31
Recruiting
260
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
2020-04-29
2023-02-10
Completed
47,079
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
2021-06-07
2029-12-31
Active, not recruiting
96
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
2022-03-07
2025-08-18
Recruiting
516
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
According to Clinical.Site data, the most researched conditions in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" are
"Gastroesophageal Junction Adenocarcinoma" (2 trials), "COVID-19" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials) and "Gastric Neoplasms" (1 trials). Many other conditions were trialed in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" in a lesser frequency.
Clinical Trials Intervention Types at Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
Most popular intervention types in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" are "Drug" (5 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Cisplatin" (2 trials), "Oxaliplatin" (2 trials), "Pembrolizumab" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
The vast majority of trials in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" are
6 trials for "All" genders.
Clinical Trials Status at Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)
Currently, there are NaN active trials in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".